#Germany #Berlin #Diabetes Technology #Medtrum #TouchCare Nano

Medtrum Advances 300U Tubeless Patch Pump for German Market

Medtrum, an innovative player in diabetes technology, is on the verge of launching its highly anticipated 300-unit (300U) tubeless patch pump in Germany. Following its presentation at the prestigious DDG 2026 held in Berlin, the product has gained recognition by being included in Germany's statutory health insurance medical aids directory. This move marks a significant development for diabetes management, especially for those who require higher daily insulin doses.

Increased Capacity for Enhanced Insulin Delivery

The 300U patch pump offers a capacity that is 50% greater than the commonly used 200-unit patch pumps. This higher reservoir capacity significantly impacts how frequently users must replace the device, making it easier for them to integrate this therapy into their daily lives. The tubeless, discreet design of the patch pump continues to be a standout feature, which aligns with Medtrum's commitment to creating more patient-centered treatment options.

Scott Yang, founder and CEO of Medtrum, expressed enthusiasm about this launch, noting that Germany is a leader in the European diabetes technology market due to its strong clinical adoption and established reimbursement frameworks. He emphasized that the introduction of the 300U patch pump exemplifies Medtrum's dedication to advancing patient care through innovative technology.

Integrating the TouchCare Nano System

The 300U tubeless patch pump is also part of Medtrum's flagship TouchCare Nano System. This comprehensive diabetes management platform combines the pump with continuous glucose monitoring and the proprietary APGO® automated insulin delivery (AID) algorithm. Additionally, the TouchCare system features a mobile app for real-time data sharing and control, enhancing user experience.

A particularly interesting aspect of this system is the Auto Meal Handling feature, which allows users to input meal types without needing to perform extensive carbohydrate calculations. This functionality aims to ease the burden of mealtime management for users, making everyday usage of automated systems more accessible.

Medtrum's Global Reach

With a presence in over 50 countries, Medtrum aims to continue its growth across Europe and beyond. The TouchCare AID System received EU MDR Class III certification in 2024, strengthening its regulatory standing in various international markets. Medtrum is committed to building partnerships with healthcare professionals and engaging in clinical collaborations to promote effective diabetes management through innovative solutions.

The upcoming 62nd EASD Annual Meeting in Milan will serve as another opportunity for Medtrum to showcase its commitment to advancing diabetes technology and patient care.

Medtrum was founded in Shanghai in 2008 and has since focused on creating integrated solutions for diabetes management. By centering its technology around the user experience, Medtrum empowers both individuals with diabetes and healthcare professionals, offering greater confidence and flexibility in managing this chronic condition.

Conclusion

The imminent launch of the 300U tubeless patch pump in Germany represents a crucial advancement in diabetes technology, allowing for better patient care and treatment options. As Medtrum continues to engage with the diabetes community and innovate its offerings, the future looks promising for people living with diabetes, enhancing their ability to manage their health effectively.